Previous close | 18.67 |
Open | 18.64 |
Bid | 18.28 x 200 |
Ask | 18.32 x 200 |
Day's range | 18.27 - 18.95 |
52-week range | 14.56 - 33.31 |
Volume | |
Avg. volume | 1,268,968 |
Market cap | 2.664B |
Beta (5Y monthly) | 1.39 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Denali Therapeutics ( NASDAQ:DNLI ) First Quarter 2024 Results Key Financial Results Net loss: US$101.8m (loss narrowed...
Denali (DNLI) Q1 loss narrows year over year due to lower expenses despite nil revenues.
Insights into Denali Therapeutics' Financial Health and Strategic Developments